112 related articles for article (PubMed ID: 23180025)
1. Irreversible electroporation: an in vivo study with dorsal skin fold chamber.
Qin Z; Jiang J; Long G; Lindgren B; Bischof JC
Ann Biomed Eng; 2013 Mar; 41(3):619-29. PubMed ID: 23180025
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
3. Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation.
Jiang C; Qin Z; Bischof J
Ann Biomed Eng; 2014 Jan; 42(1):193-204. PubMed ID: 23949655
[TBL] [Abstract][Full Text] [Related]
4. Changes of apoptosis in tumor tissues with time after irreversible electroporation.
Kim HB; Sung CK; Baik KY; Moon KW; Kim HS; Yi JH; Jung JH; Moon MH; Choi OK
Biochem Biophys Res Commun; 2013 Jun; 435(4):651-6. PubMed ID: 23688425
[TBL] [Abstract][Full Text] [Related]
5. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
Neal RE; Davalos RV
Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models.
José A; Sobrevals L; Ivorra A; Fillat C
Cancer Lett; 2012 Apr; 317(1):16-23. PubMed ID: 22079741
[TBL] [Abstract][Full Text] [Related]
9. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment.
Neal RE; Rossmeisl JH; D'Alfonso V; Robertson JL; Garcia PA; Elankumaran S; Davalos RV
Ann Biomed Eng; 2014 Mar; 42(3):475-87. PubMed ID: 24165928
[TBL] [Abstract][Full Text] [Related]
10. Pulse timing during irreversible electroporation achieves enhanced destruction in a hindlimb model of cancer.
Jiang C; Shao Q; Bischof J
Ann Biomed Eng; 2015 Apr; 43(4):887-95. PubMed ID: 25269611
[TBL] [Abstract][Full Text] [Related]
11. A review of basic to clinical studies of irreversible electroporation therapy.
Jiang C; Davalos RV; Bischof JC
IEEE Trans Biomed Eng; 2015 Jan; 62(1):4-20. PubMed ID: 25389236
[TBL] [Abstract][Full Text] [Related]
12. Optimal parameters for the destruction of prostate cancer using irreversible electroporation.
Rubinsky J; Onik G; Mikus P; Rubinsky B
J Urol; 2008 Dec; 180(6):2668-74. PubMed ID: 18951581
[TBL] [Abstract][Full Text] [Related]
13. Electrical and thermal analyses of catheter-based irreversible electroporation of digestive tract.
Ren F; Li Q; Gao X; Zhu K; Zhang J; Chen X; Yan X; Chu D; Hu L; Gao Z; Wu Z; Wu R; Lv Y
Int J Hyperthermia; 2019; 36(1):854-867. PubMed ID: 31452435
[No Abstract] [Full Text] [Related]
14. Irreversible electroporation attenuates neointimal formation after angioplasty.
Maor E; Ivorra A; Leor J; Rubinsky B
IEEE Trans Biomed Eng; 2008 Sep; 55(9):2268-74. PubMed ID: 18713696
[TBL] [Abstract][Full Text] [Related]
15. In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome.
Ivorra A; Al-Sakere B; Rubinsky B; Mir LM
Phys Med Biol; 2009 Oct; 54(19):5949-63. PubMed ID: 19759406
[TBL] [Abstract][Full Text] [Related]
16. Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer.
Shao Q; Liu F; Chung C; Elahi-Gedwillo K; Provenzano PP; Forsyth B; Bischof JC
Ann Biomed Eng; 2018 Jan; 46(1):25-36. PubMed ID: 28983745
[TBL] [Abstract][Full Text] [Related]
17. Effects of bipolar irreversible electroporation with different pulse durations in a prostate cancer mouse model.
Kim SH; Kang JM; Park Y; Kim Y; Lim B; Park JH
Sci Rep; 2024 Apr; 14(1):9902. PubMed ID: 38688960
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation.
Shafiee H; Garcia PA; Davalos RV
J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145
[TBL] [Abstract][Full Text] [Related]
19. Antitumour effect of electrochemotherapy with bleomycin on human prostate cancer xenograft.
Ueki T; Uemura H; Nagashima Y; Ohta S; Ishiguro H; Kubota Y
BJU Int; 2008 Nov; 102(10):1467-71. PubMed ID: 18549430
[TBL] [Abstract][Full Text] [Related]
20. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue.
Garcia PA; Davalos RV; Miklavcic D
PLoS One; 2014; 9(8):e103083. PubMed ID: 25115970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
